Endogenous Metabolite (EM) Information
| Endogenous Metabolite (EM) Information | ||||||
|---|---|---|---|---|---|---|
| EM ID |
EM00079
|
|||||
| EM Name |
Glycocholic acid
|
|||||
| Synonyms |
Glycocholic acid; glycocholate; Cholylglycine; N-Choloylglycine; Glycine, N-choloyl-; UNII-G59NX3I3RT; N-CHOLYLGLYCINE; G59NX3I3RT; CHEMBL411070; Glycine, N-((3alpha,5beta,7alpha,12alpha)-3,7,12-trihydroxy-24-oxocholan-24-yl)-; 3alpha,7alpha,12alpha-trihydroxy-5beta-cholan-24-oylglycine; Glycocholic acid hydrate; C26H43NO6; N-(3alpha,7alpha,12alpha-trihydroxy-5beta-cholan-24-oyl)glycine; N-(3Alpha,7Alpha,12Alpha-trihydroxy-5Beta-cholan-24-oyl)-glycine
|
|||||
| Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=10140"></iframe>
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C26H43NO6
|
|||||
| Canonical SMILES |
CC(CCC(=O)NCC(=O)O)C1CCC2C1(C(CC3C2C(CC4C3(CCC(C4)O)C)O)O)C
|
|||||
| InChI |
InChI=1S/C26H43NO6/c1-14(4-7-22(31)27-13-23(32)33)17-5-6-18-24-19(12-21(30)26(17,18)3)25(2)9-8-16(28)10-15(25)11-20(24)29/h14-21,24,28-30H,4-13H2,1-3H3,(H,27,31)(H,32,33)/t14-,15+,16-,17-,18+,19+,20-,21+,24+,25+,26-/m1/s1
|
|||||
| InChIKey |
RFDAIACWWDREDC-FRVQLJSFSA-N
|
|||||
| CAS Number |
CAS 475-31-0
|
|||||
| Pharmaceutical Properties | Molecular Weight | 465.6 | Topological Polar Surface Area | 127 | ||
| Heavy Atom Count | 33 | Rotatable Bond Count | 6 | |||
| Hydrogen Bond Donor Count | 5 | Hydrogen Bond Acceptor Count | 6 | |||
| PubChem CID | ||||||
| ChEBI ID |
CHEBI:17687
|
|||||
| DT(s) "handling" This EM | ABCD1 | Transporter Info | Adrenoleukodystrophy protein | [1] | ||
| References | ||||||
| 1 | Altered glycolipid and glycerophospholipid signaling drive inflammatory cascades in adrenomyeloneuropathy. Hum Mol Genet. 2015 Dec 15;24(24):6861-76. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.